According to The NewYork Times, it has been discovered that women who detect breast cancer at early stages do not need chemotherapy as part of their medical treatment. This was confirmed after a research was conducted by a group of medical doctors and scientists.

The study discovered that women who had early stages of breast cancer could use a drug blocking therapy whereby they are administered a drug that blocks hormone estrogen or stops the body from producing it.

The hormone-blocking drug called tamoxifen and other related medicines is known as endocrine therapy which is now regarded as an essential part of treatment for most women because they lower the risks of recurrence, new breast tumours and death from the disease.

We can spare thousands and thousands of women from getting toxic treatment that really wouldn’t benefit them. “This is very powerful. It really changes the standard of care.” said Dr Ingrid A. Mayer, from Vanderbilt University Medical Center, an author of the study.

The study which began in 2006 is called TAILORx and was paid for by the United States, Canadian Governments and Philanthropic Groups. The findings from this study apply to about 60,000 women and according to Dr Sparano, the leader of the study, this means that about 70% of women can spare chemotherapy based on clinical features.

Although it has also be stated that endocrine therapy has side effects, which can include hot flashes and other symptoms of menopause, weight gain and pain in joints and muscles. While tamoxifen can increase the risk of cancer of the uterus the study still proves to have a wider effort to fine-tune treatments and spare patients from harsh side effects whenever possible.

Click here to read more about the study.

There are no comments

Add yours